This is great new in my opinion. Looks to me that the FDA see this as a winner, I wonder if they also stumbled across other benefits that they want to discuss.
Either way I’ve been topping up on this one with every spare cent I have, I’m hoping this one might be my early retirement fund
Ann: Meeting with US FDA on Phase I Clinical Trial for RECCE 327, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $104.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $87.14K | 248.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23061 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 20951 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |